Showing results (111-120 of 133) with videos related to
Sort By:
Pageof 14
Breast (Edinburgh, Scotland)|February 3, 2012
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyAndrew Fong, Jesmin Shafiq, Christobel Saunders, et al.International Journal of Radiation Oncology, Biology, Physics|January 24, 2026
Treatment With Stereotactic Ablative Radiotherapy for patients with Up to 5 Oligometastatic cancer lesions: Long-Term Outcomes of the Nonrandomized Population-Based Phase 2 SABR-5 Clinical TrialCurtis Leclerc, Sarah Baker, Will Jiang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline EndorsementRonald C Chen, R Bryan Rumble, D Andrew Loblaw, et al.International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapyTanya S Berrang, Ivo Olivotto, Do-Hoon Kim, et al.Healthcare Management Forum|December 22, 2017
Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and researchRobert A Olson, Fuchsia Howard, Vincent Lapointe, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 1, 2019
Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancerSunil Parimi, Suraya Bondy, Erica Tsang, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 TrialSarah Baker, Benjamin Mou, Will Jiang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapyEmily O'Reilly, Eshawn Johal, Haley Clark, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2025
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 TrialSarah Baker, Curtis Leclerc, Hanna Atmanspacher-Wirth, et al.Pageof 14